145 related articles for article (PubMed ID: 37788567)
21. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
[TBL] [Abstract][Full Text] [Related]
22. Opioid use disorder among hospitalized adults in North Carolina: Comparative analysis of national and statewide trends.
Alemu BT; McCague EA; Holt N; Baron PA; Olayinka O; Martin BC
J Opioid Manag; 2021; 17(4):343-352. PubMed ID: 34533829
[TBL] [Abstract][Full Text] [Related]
23. Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method.
Doogan NJ; Mack A; Wang J; Crane D; Jackson R; Applegate M; Villani J; Chandler R; Barocas JA
Am J Epidemiol; 2022 Nov; 191(12):2098-2108. PubMed ID: 36004683
[TBL] [Abstract][Full Text] [Related]
24. Psycho-Social Correlates of Opioid Use Disorder among the US Adult Population: Evidence from the National Survey on Drug Use and Health, 2015-2018.
Haider MR; Brown MJ; Gupta RD; Karim S; Olatosi B; Li X
Subst Use Misuse; 2020; 55(12):2002-2010. PubMed ID: 32633664
[TBL] [Abstract][Full Text] [Related]
25. County-Level Social Vulnerability and Emergency Department Visits for Firearm Injuries - 10 U.S. Jurisdictions, January 1, 2018-December 31, 2021.
Van Dyke ME; Chen MS; Sheppard M; Sharpe JD; Radhakrishnan L; Dahlberg LL; Simon TR; Zwald ML
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(27):873-877. PubMed ID: 35797204
[TBL] [Abstract][Full Text] [Related]
26. Social Vulnerability, Prevalence of Glaucoma, and Incidence of Glaucoma Surgery in the California Medicare Population.
Tseng VL; Kitayama K; Yu F; Pan D; Coleman AL
Ophthalmol Glaucoma; 2023; 6(6):616-625. PubMed ID: 37211091
[TBL] [Abstract][Full Text] [Related]
27. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
28. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
Taylor EA; Cantor JH; Bradford AC; Simon K; Stein BD
JAMA Netw Open; 2023 May; 6(5):e2314328. PubMed ID: 37204793
[TBL] [Abstract][Full Text] [Related]
29. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
Abraham AJ; Adams GB; Bradford AC; Bradford WD
Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of opioid use disorder in Kentucky's counties: A two-year multi-sample capture-recapture analysis.
Thompson K; Barocas JA; Delcher C; Bae J; Hammerslag L; Wang J; Chandler R; Villani J; Walsh S; Talbert J
Drug Alcohol Depend; 2023 Jan; 242():109710. PubMed ID: 36469995
[TBL] [Abstract][Full Text] [Related]
31. Emergency department presentation of opioid use disorder and alcohol use disorder.
Xierali IM; Day PG; Kleinschmidt KC; Strenth C; Schneider FD; Kale NJ
J Subst Abuse Treat; 2021 Aug; 127():108343. PubMed ID: 34134862
[TBL] [Abstract][Full Text] [Related]
32. Trends of Opioid Use Disorder Among Hospitalized Patients With Chronic Pain.
Orhurhu V; Olusunmade M; Urits I; Viswanath O; Peck J; Orhurhu MS; Adekoya P; Hirji S; Sampson J; Simopoulos T; Jatinder G
Pain Pract; 2019 Jul; 19(6):656-663. PubMed ID: 31077526
[TBL] [Abstract][Full Text] [Related]
33. Availability of Medications for Alcohol Use Disorder Treatment in Medicare Part D, 2014-2018.
Harris SJ; Abraham AJ; Yarbrough CR
J Stud Alcohol Drugs; 2022 Sep; 83(5):653-661. PubMed ID: 36136435
[TBL] [Abstract][Full Text] [Related]
34. Association of County-degree Social Vulnerability with Chronic Respiratory Disease Mortality in the United States.
Lee YC; Chang KY; Mirsaeidi M
Ann Am Thorac Soc; 2023 Jan; 20(1):47-57. PubMed ID: 36044720
[No Abstract] [Full Text] [Related]
35. Investigation of barriers to county-level seasonal influenza vaccine uptake among Medicare beneficiaries in the United States - 2018-2019 seasonal influenza season.
Cho BH; O'Halloran A; Pike J
Vaccine X; 2023 Aug; 14():100326. PubMed ID: 37577260
[TBL] [Abstract][Full Text] [Related]
36. The association between community social vulnerability and prescription opioid availability with individual opioid overdose.
El Ibrahimi S; Hendricks MA; Little K; Ritter GA; Flores D; Loy B; Wright D; Weiner SG
Drug Alcohol Depend; 2023 Nov; 252():110991. PubMed ID: 37862877
[TBL] [Abstract][Full Text] [Related]
37. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
38. Association of injury after prescription opioid initiation with risk for opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study.
Wei YJ; Chen C; Cheng TD; Schmidt SO; Fillingim RB; Winterstein AG
PLoS Med; 2022 Sep; 19(9):e1004101. PubMed ID: 36136971
[TBL] [Abstract][Full Text] [Related]
39. Opioid Use Disorder Among the Economically Disadvantaged in the Rural South.
Albright DL; Suntai Z; McDaniel JT; Johnson K; Henson H; Robertson E; McIntosh S
J Addict Med; 2023 Jul-Aug 01; 17(4):418-423. PubMed ID: 37579099
[TBL] [Abstract][Full Text] [Related]
40. County Social Vulnerability and Influenza Vaccine Rates: National and Local Estimates for Medicare Recipients.
Strully KW; Yang TC
Am J Prev Med; 2022 Jan; 62(1):e1-e9. PubMed ID: 34548222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
